BioCentury
ARTICLE | Company News

PolyTherics, Tube Pharmaceuticals deal

October 21, 2013 7:00 AM UTC

PolyTherics and Tube partnered to develop antibody-drug conjugates (ADCs) to treat cancer using PolyTherics' ThioBridge conjugation technology and Tube's cytotoxic synthetic tubulin binding agents ca...